MNRO

Monro, Inc.

50
Fundamentals54/ 100
Valuation50/ 100
Upside potential60/ 100
Risk potential34/ 100

MNRO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO has the edge over MNRO overall, supported by stronger fundamentals and lower modeled downside.

MNRO Fundamentals

MetricStatus
Stable
Stable
Under pressure
Healthy

MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

MNRO PE Valuation

MNRO has no meaningful PE right now: it lost money over the past year.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

MNRO Forward outlook

MetricOutlook
--
Turning to a loss
Stable
Weakening
Limited
High

Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

NIO has the edge over MNRO on the outlook, with more favorable earnings and revenue expectations.

MNRO Risk to reward

ScenarioChangePrice
Upside+50%$15.51
Downside-34%$6.88

Calculated from the latest close: $10.36 on Nov 12.

MNRO has a better modeled risk to reward balance than NIO, with more potential upside relative to its potential downside.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO trails MNRO on modeled risk to reward, with less potential upside relative to its potential downside.

MNRO Earnings Per Share

Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
Q4 2023: $1.08Q1 2024: $1.18Q2 2024: $1.09Q3 2024: $0.87Q4 2024: $0.64Q1 2025: $-0.22Q2 2025: $-0.69Q3 2025: $-0.69Q4 2025: $-0.49Q1 2026: $0.03Q2 2026: $0.23Q3 2026: $0.00
QuarterTTM EPSYoY
Q3 2026$0.00+$0.69
Q2 2026$0.23+$0.92
Q1 2026$0.03+$0.25
Q4 2025-$0.49-177%
Q3 2025-$0.69-179%
Q2 2025-$0.69-163%
Q1 2025-$0.22-119%
Q4 2024$0.64-41%

MNRO is still losing money, but far less than before: $0.00 per share over the past year, against $0.69 at its worst in mid-2025.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO has the edge over MNRO on earnings, with more consistent year-over-year improvement.

MNRO Quarterly Revenue

Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
Q4 2023: $318MQ1 2024: $310MQ2 2024: $293MQ3 2024: $301MQ4 2024: $306MQ1 2025: $295MQ2 2025: $301MQ3 2025: $289MQ4 2025: $293MQ1 2026: $274MQ2 2026: $287MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$283.6M-1.8%
Q2 2026$287.1M-4.6%
Q1 2026$273.8M-7.2%
Q4 2025$293.4M-4%
Q3 2025$288.9M-4.1%
Q2 2025$301M+2.7%
Q1 2025$295M-4.9%
Q4 2024$305.8M-3.7%

MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO has the edge over MNRO on sales, with more consistent year-over-year improvement.

MNRO Free Cash Flow

Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
Q4 2023: $29MQ1 2024: −$12MQ2 2024: $17MQ3 2024: $58MQ4 2024: $8MQ1 2025: $23MQ2 2025: −$9MQ3 2025: $27MQ4 2025: $9MQ1 2026: $12MQ2 2026: −$38MQ3 2026: $29M
QuarterFree cash flowYoY
Q3 2026$28.8M+8.2%
Q2 2026-$37.9M-$28.6M
Q1 2026$12.4M-47%
Q4 2025$9.1M+15%
Q3 2025$26.6M-54%
Q2 2025-$9.3M-156%
Q1 2025$23.2M+$35.1M
Q4 2024$7.9M-73%

MNRO still generates free cash flow, though less than at its 2022 peak: $12M over the past year.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO has the edge over MNRO on cash flow, with more consistent year-over-year improvement.

MNRO Total Shares

Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
Q4 2023: 32MQ1 2024: 32MQ2 2024: 31MQ3 2024: 31MQ4 2024: 31MQ1 2025: 30MQ2 2025: 30MQ3 2025: 31MQ4 2025: 31MQ1 2026: 30MQ2 2026: 30MQ3 2026: 31M
PeriodChange %Net change
Quarterly+3.8%+1.1M shares
1 year-0.2%-68K shares
3 years-3%-977K shares
5 years-8%-2.7M shares
Available history-7.9%-2.7M shares

MNRO has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

MNRO Net Leverage

Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
Q4 2023: 0.8xQ1 2024: 0.9xQ2 2024: 1.0xQ3 2024: 0.6xQ4 2024: 0.8xQ1 2025: 1.0xQ2 2025: 1.7xQ3 2025: 1.5xQ4 2025: 1.2xQ1 2026: 1.0xQ2 2026: 1.5xQ3 2026: 1.5x
QuarterNet LeverageStatus
Q3 20261.5xHealthy
Q2 20261.5xHealthy
Q1 20261.0xHealthy
Q4 20251.2xHealthy
Q3 20251.5xHealthy
Q2 20251.7xHealthy
Q1 20251.0xVery low
Q4 20240.8xVery low

MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

MNRO Weekly Momentum

MetricValueStatus
RSI34.0Neutral
Stochastic5.4Oversold

MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

MNRO PE vs Consumer Cyclical Sector

MetricMNROSector medianRelative
PE58x18x219% above
PE %854738 pts above

MNRO has no meaningful PE right now: it lost money over the past year.

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

MNRO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.718% below
20 week MA$13.523% below
50 week MA$16.437% below
100 week MA$16.838% below
200 week MA$25.159% below

MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

MNRO Yearly ROI

YearStart priceEnd priceROI
2020$78.9$53.1-33%
2021$53.1$59.2+11%
2022$59.2$45.2-24%
2023$45.2$29.3-35%
2024$29.3$24.8-16%
2025$24.8$20.8-16%
2026 YTD$20.8$10.4-50%

MNRO has finished four years in a row lower, and it's down 50% so far in 2026.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO has the edge over MNRO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key